Acute	acute	O	O
low	low	O	B_disease
back	back	O	B_disease
pain	pain	O	S_disease
during	during	O	O
intravenous	intravenous	O	O
administration	administration	O	O
of	of	O	O
amiodarone	amiodarone	S_chemical	O
:	:	O	O
a	a	O	O
report	report	O	O
of	of	O	O
two	two	O	O
cases	cases	O	O
.	.	O	O

Amiodarone	amiodarone	S_chemical	O
represents	represents	O	O
an	an	O	O
effective	effective	O	O
antiarrhythmic	antiarrhythmic	O	O
drug	drug	O	O
for	for	O	O
cardioversion	cardioversion	O	O
of	of	O	O
recent-onset	recent-onset	O	O
atrial	atrial	O	B_disease
fibrillation	fibrillation	O	I_disease
(	(	O	O
AF	af	O	O
)	)	O	O
and	and	O	O
maintenance	maintenance	O	O
of	of	O	O
sinus	sinus	O	O
rhythm	rhythm	O	O
.	.	O	O

We	we	O	O
briefly	briefly	O	O
describe	describe	O	O
two	two	O	O
patients	patients	O	O
suffering	suffering	O	O
from	from	O	O
recent-onset	recent-onset	O	O
atrial	atrial	O	B_disease
fibrillation	fibrillation	O	I_disease
,	,	O	O
who	who	O	O
experienced	experienced	O	O
an	an	O	O
acute	acute	O	O
devastating	devastating	O	O
low	low	O	B_disease
back	back	O	B_disease
pain	pain	O	S_disease
a	a	O	O
few	few	O	O
minutes	minutes	O	O
after	after	O	O
initiation	initiation	O	O
of	of	O	O
intravenous	intravenous	O	O
amiodarone	amiodarone	S_chemical	O
loading	loading	O	O
.	.	O	O

Notably	notably	O	O
,	,	O	O
this	this	O	O
side	side	O	O
effect	effect	O	O
has	has	O	O
not	not	O	O
been	been	O	O
ever	ever	O	O
reported	reported	O	O
in	in	O	O
the	the	O	O
medical	medical	O	O
literature	literature	O	O
.	.	O	O

Clinicians	clinicians	O	O
should	should	O	O
be	be	O	O
aware	aware	O	O
of	of	O	O
this	this	O	O
reaction	reaction	O	O
since	since	O	O
prompt	prompt	O	O
termination	termination	O	O
of	of	O	O
parenteral	parenteral	O	O
administration	administration	O	O
leads	leads	O	O
to	to	O	O
complete	complete	O	O
resolution	resolution	O	O
.	.	O	O

